CME Supplements

Finding Balance: New Strategies to Optimize Care for Patients With Parkinson’s Disease Psychosis

Publish date: September 7, 2016

 

This activity is jointly provided by Postgraduate Institute for Medicine and MedEdicus LLC.

This activity is supported by an independent educational grant from ACADIA Pharmaceuticals LLC

After reading this CME supplement, health care providers will have improved their ability to:

  • Discuss the clinical features and risk factors for Parkinson's disease psychosis (PDP)
  • Develop individualized pharmacologic treatment plans for patients with PDP that consider motor and nonmotor symptoms
  • Evaluate the mechanism of action, tolerability, safety, and efficacy of pharmacologic treatment options for PDP
  • Employ multidisciplinary communication strategies to improve quality of life in patients with PDP

This CME supplement entitles the reader to 1.0 AMA PRA Category 1 Credit™
Click here to read supplement.
After reading the supplement, click here to access the CME posttest

Recommended Reading

VIDEO: Withdrawing antipsychotics is safe and feasible in long-term care
MDedge Neurology
Amyloid pathology associated with neuropsychiatric symptoms in MCI
MDedge Neurology
MRI measurements reveal effects of sleep deprivation
MDedge Neurology
Clot retrieval devices approved for initial ischemic stroke treatment
MDedge Neurology
ACOs score slight bump in bonus payments
MDedge Neurology